arrow
E

Elo Andersen

copenhagen university
H指数:44
被引数:7,478

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluation of decentralised model-based selection of head and neck cancer patients for a proton treatment study. DAHANCA 35

质子治疗研究中基于分散模型的头颈癌患者选择的评估。达汉卡35

2024-01-0114
OAAI
The Incidence, Survival, and HPV Impact of Second Primary Cancer following Primary Oropharyngeal Squamous Cell Carcinoma: A 20-Year Retrospective and Population-Based Study

原发性口咽鳞状细胞癌后第二原发癌的发病率、生存率和HPV影响: 一项基于人群的20年回顾性研究

2022-12-226
OAAI
Intraglandular Off-the-Shelf Allogeneic Mesenchymal Stem Cell Treatment in Patients with Radiation-Induced Xerostomia: A Safety Study (MESRIX-II)
2022-04-1829
OAAI
Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts

HPV阳性口咽癌的确定性 (化学) 放疗后的治疗结果和生存率: DAHANCA与PMH队列的大规模比较

2021-12-0221
OA
Bloodstream infections in head and neck cancer patients after curative-intent radiotherapy: a population-based study from the Danish Head and Neck Cancer Group database

根治性放疗后头颈癌患者的血流感染: 来自丹麦头颈癌组数据库的基于人群的研究

2021-05-205
OAAI
The Danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines

丹麦头颈癌组 (DAHANCA) 2020放射治疗指南

2020-10-0172
PREAI
The Copenhagen Oral Cavity Squamous Cell Carcinoma database: protocol and report on establishing a comprehensive oral cavity cancer database
2019-08-0118
OAAI
Safety and Efficacy of Mesenchymal Stem Cells for Radiation-Induced Xerostomia: A Randomized, Placebo-Controlled Phase 1/2 Trial (MESRIX)
2018-07-0189
PREAI